AbbVie Inc. (ABBV)

NYQ – Real Time Price. Currency in USD

249.83

-0.26 (-0.10%)

Market open: Aug 12, 2026, 11:24 AM EDT

249.90

-0.19 (-0.08%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

10.08.2026

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed.

10.08.2026

Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?

AbbVie's growth rate was more than 10% this past quarter and has been rising in recent years. Its valuation may seem high, but acquisition-related expenses have weighed on its bottom line.

10.08.2026

3 Beaten-Down Healthcare Stocks to Buy in August

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

07.08.2026

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie relies on a high-margin biopharmaceutical portfolio and significant free cash flow to drive shareholder value. Abbott Laboratories leverages a highly diversified business model spanning medical devices, diagnostics, and nutritional products.

06.08.2026

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

ABBV falls after cutting its 2026 EPS outlook to reflect the Apogee deal, despite strong Q2 results, higher revenue guidance and growth from key medicines.

06.08.2026

Stock Picks From Seeking Alpha's July 2026 New Analysts

Seeking Alpha welcomed 33 new analysts in July 2026. This article showcases their top picks and investment strategies. Highlighted companies include SELLAS Life Sciences, Chevron, B2Gold, Amazon, and QXO, each with detailed investment theses. Analysts emphasize asymmetric opportunities, event-driven catalysts, balance sheet strength, market structure, and sector-specific growth or risk factors.

05.08.2026

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
ABBV	Erste Group	Buy	undefined >> undefined	August 5th 2026

Press releases

04.08.2026

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

If approved, BOTOX ® Cosmetic (onabotulinumtoxinA) would be the only neurotoxin with five aesthetic indications and the first and only approved for masseter muscle prominence in the U.S. Submission is supported by two Phase 3 studies (M21-416 and M21-417), demonstrating statistically significant improvements in masseter muscle prominence and patient satisfaction with treatment IRVINE, Calif., Aug. 4, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for BOTOX® Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of marked to very marked masseter muscle prominence (MMP) associated with masseter muscle activity in adults.

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbbVie Inc. (ABBV)

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?

3 Beaten-Down Healthcare Stocks to Buy in August

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

Stock Picks From Seeking Alpha's July 2026 New Analysts

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Videos

No Data

Upgrades / Downgrades

Press releases

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?

3 Beaten-Down Healthcare Stocks to Buy in August

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

Stock Picks From Seeking Alpha's July 2026 New Analysts

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Videos

No Data

Upgrades / Downgrades

Press releases

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

Search stocks

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbbVie Inc. (ABBV)

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?

3 Beaten-Down Healthcare Stocks to Buy in August

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

Stock Picks From Seeking Alpha's July 2026 New Analysts

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Videos

No Data

Upgrades / Downgrades

Press releases

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?

3 Beaten-Down Healthcare Stocks to Buy in August

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

Stock Picks From Seeking Alpha's July 2026 New Analysts

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Videos

No Data

Upgrades / Downgrades

Press releases

Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence